Search research articles
Contact Us
Filters
Showing results (81-90 of 125) with videos related to
Page
of 13
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 7, 2004
Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer
Bart de Keizer, Anne Hoekstra, Mark W Konijnenberg, et al.
Molecular Cancer Therapeutics
|
December 17, 2008
Monoclonal antibody 14C5 targets integrin alphavbeta5
Ingrid Burvenich, Steve Schoonooghe, Liesbet Vervoort, et al.
Plos One
|
June 24, 2017
Estimation of the optimal dosing regimen of escitalopram in dogs: A dose occupancy study with [11C]DASB
Olivia Taylor, Nick Van Laeken, Ingeborgh Polis, et al.
BMC Veterinary Research
|
December 26, 2015
In vivo quantification of the [(11)C]DASB binding in the normal canine brain using positron emission tomography
Olivia Taylor, Nick Van Laeken, Filip De Vos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 26, 2010
Measurement of porto-systemic shunting in mice by novel three-dimensional micro-single photon emission computed tomography imaging enabling longitudinal follow-up
Christophe Van Steenkiste, Steven Staelens, Steven Deleye, et al.
Plos One
|
October 4, 2016
Correction: Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats
Julie Bolcaen, Kelly Lybaert, Lieselotte Moerman, et al.
Plos One
|
August 26, 2016
Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats
Julie Bolcaen, Kelly Lybaert, Lieselotte Moerman, et al.
Nuclear Medicine Communications
|
December 4, 2004
Importance of receptor density in alpha radioimmunotherapy in B cell malignancies: an in-vitro study
Katia Vandenbulcke, Hubert Thierens, Fritz Offner, et al.
Journal of Cancer Survivorship : Research and Practice
|
October 2, 2023
Work-related experiences and unmet needs of patients with a malignant glioma and relevant professionals: the BrainWork study
Amber Daniëlle Zegers, Pieter Coenen, Amy Heeren, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
September 27, 2006
In vitro screening for synergism of high-linear energy transfer 213Bi-radiotherapy with other therapeutic agents for the treatment of B-cell chronic lymphocytic leukemia
Katia Vandenbulcke, Hubert Thierens, Filip De Vos, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 125) with videos related to
Sort By:
Page
of 13
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 7, 2004
Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer
Bart de Keizer, Anne Hoekstra, Mark W Konijnenberg, et al.
Molecular Cancer Therapeutics
|
December 17, 2008
Monoclonal antibody 14C5 targets integrin alphavbeta5
Ingrid Burvenich, Steve Schoonooghe, Liesbet Vervoort, et al.
Plos One
|
June 24, 2017
Estimation of the optimal dosing regimen of escitalopram in dogs: A dose occupancy study with [11C]DASB
Olivia Taylor, Nick Van Laeken, Ingeborgh Polis, et al.
BMC Veterinary Research
|
December 26, 2015
In vivo quantification of the [(11)C]DASB binding in the normal canine brain using positron emission tomography
Olivia Taylor, Nick Van Laeken, Filip De Vos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 26, 2010
Measurement of porto-systemic shunting in mice by novel three-dimensional micro-single photon emission computed tomography imaging enabling longitudinal follow-up
Christophe Van Steenkiste, Steven Staelens, Steven Deleye, et al.
Plos One
|
October 4, 2016
Correction: Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats
Julie Bolcaen, Kelly Lybaert, Lieselotte Moerman, et al.
Plos One
|
August 26, 2016
Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats
Julie Bolcaen, Kelly Lybaert, Lieselotte Moerman, et al.
Nuclear Medicine Communications
|
December 4, 2004
Importance of receptor density in alpha radioimmunotherapy in B cell malignancies: an in-vitro study
Katia Vandenbulcke, Hubert Thierens, Fritz Offner, et al.
Journal of Cancer Survivorship : Research and Practice
|
October 2, 2023
Work-related experiences and unmet needs of patients with a malignant glioma and relevant professionals: the BrainWork study
Amber Daniëlle Zegers, Pieter Coenen, Amy Heeren, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
September 27, 2006
In vitro screening for synergism of high-linear energy transfer 213Bi-radiotherapy with other therapeutic agents for the treatment of B-cell chronic lymphocytic leukemia
Katia Vandenbulcke, Hubert Thierens, Filip De Vos, et al.
Page
of 13